ALLYSSA FINER: Open Payments
NPI 1104301431 · GREEN BROOK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$472 in 19 payments from 8 companies in 2025. Trend: 2023 $229 · 2024 $168 · 2025 $472
Food & beverage: $472
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $185 |
| Novo Nordisk Inc | 5 | $83 |
| Lilly USA, LLC | 4 | $71 |
| ABBVIE INC. | 3 | $51 |
| Seqirus USA Inc | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Abbott Laboratories | 1 | $15 |
Products named: AIRSUPRA, MOUNJARO, UBRELVY, Flucelvax, Kerendia, QULIPTA, Wegovy, GARDASIL 9.
Industry payments across NJ — which companies pay providers there.
